rethinkTHC Search
Menu
Study breakdown

50 Years After THC: How the Endocannabinoid System Works Throughout the Body

ReviewStrong evidence
The takeaway

A landmark review by pioneers of cannabinoid research mapped the endocannabinoid system's roles across peripheral organs, revealing its involvement in reproduction, bone metabolism, skin health, immune function, and gastrointestinal regulation.

Read this if you want to understand how the endocannabinoid system works throughout the body, not just the brain.

Endocannabinoids regulate cell fate in nearly every organ system

What the researchers found

Written by many of the scientists who discovered key components of the endocannabinoid system, this comprehensive review examined how endocannabinoids function throughout the body beyond the brain.

The endocannabinoid system was found to control fundamental biological processes including cell survival, death, and differentiation across nearly every organ system. Specific roles were mapped in reproduction (embryo implantation, pregnancy maintenance), bone metabolism (bone density regulation), skin (barrier function, hair growth, sebum production), immune function (inflammation modulation), and gastrointestinal health (motility, secretion, inflammation).

The review established consensus that the peripheral endocannabinoid system is among the most widespread signaling systems in the human body.

Why it matters

This authoritative review, written by the founders of the field, established that the endocannabinoid system is not primarily a "brain thing" but a body-wide regulatory network. This understanding is fundamental to evaluating how cannabis use affects overall health.

The numbers in context

THC isolated in 1964; anandamide discovered 1992; 2-AG discovered 1995; 12 co-authors including field pioneers; coverage spans reproductive, skeletal, dermatological, immunological, and gastrointestinal systems

How the study worked

Collaborative review authored by 12 leading endocannabinoid researchers, including Raphael Mechoulam (who first isolated THC in 1964). Synthesized decades of basic science and clinical research on peripheral endocannabinoid function.

What this study cannot tell us

As a narrative review by field leaders, it may emphasize the importance of the endocannabinoid system. Some findings are from animal models with uncertain human translation. The therapeutic potential discussed remains largely unrealized.

How to read the evidence

Comprehensive review authored by the field's founders, synthesizing decades of research. Represents authoritative consensus on peripheral endocannabinoid function.

When this study was published

Published in 2015, marking 50+ years since THC isolation. Peripheral endocannabinoid research has continued to expand.

The bigger picture

Understanding that endocannabinoids regulate cell fate decisions across virtually every organ system explains why cannabis can have such wide-ranging effects on health. It also points to therapeutic potential far beyond pain and nausea.

Questions still open

  • Can the peripheral endocannabinoid system be targeted therapeutically without central nervous system side effects? How does chronic cannabis use alter peripheral endocannabinoid function? Which peripheral applications are closest to clinical translation?

Common questions

What is the endocannabinoid system?
It is a network of receptors, signaling molecules (endocannabinoids like anandamide and 2-AG), and enzymes found throughout the body. It regulates numerous biological processes including pain, inflammation, mood, appetite, bone density, reproduction, and immune function.
Does this mean cannabis affects the whole body?
Yes. Because the endocannabinoid system exists throughout the body, THC and other cannabinoids from cannabis can affect nearly every organ system, not just the brain. This explains both the wide range of potential therapeutic effects and side effects.

Read the original research

Endocannabinoid signaling at the periphery: 50 years after THC.

Trends in pharmacological sciences, 36(5), 277-96

Citation

Maccarrone, Mauro; Bab, Itai; Bíró, Tamás; Cabral, Guy A; Dey, Sudhansu K; Di Marzo, Vincenzo; Konje, Justin C; Kunos, George; Mechoulam, Raphael; Pacher, Pal; Sharkey, Keith A; Zimmer, Andreas. (2015). Endocannabinoid signaling at the periphery: 50 years after THC.. Trends in pharmacological sciences, 36(5), 277-96. https://doi.org/10.1016/j.tips.2015.02.008

Explore the wider topic